✦ LIBER ✦

Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept

✍ Scribed by Paul S. Yamauchi; Logan Turner; Nicholas J. Lowe; Vivian Gindi; J. Mark Jackson

Book ID: 116581494
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 206 KB
Volume: 54
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2005.11.1089

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of sweet's syndrome with the t

Treatment of sweet's syndrome with the tumor necrosis factor antagonist etanercept in a patient with coexisting rheumatoid arthritis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Treatment of coexisting bullous pemphigo

Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept

✍ Paul S. Yamauchi; Nicholas J. Lowe; Vivian Gindi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Treatment of coexisting bullous pemphigo

Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Treatment of necrobiosis lipoidica with

Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept

✍ Joshua A. Zeichner; Dana W.K. Stern; Mark Lebwohl 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Treatment of recalcitrant cicatricial pe

Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor α antagonist etanercept

✍ Christopher Sacher; Andrea Rubbert; Cathrin König; Karin Scharffetter-Kochanek; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Treatment with tumor necrosis factor inh

Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis

✍ Lotta Ljung; Julia F. Simard; Lennart Jacobsson; Solbritt Rantapää-Dahlqvist; Jo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 3 views

## Abstract ## Objective Rheumatoid arthritis (RA) is associated with an increased risk of ischemic heart disease, in both early and established RA. Data on the risk of ischemic heart disease in relation to therapy with tumor necrosis factor (TNF) antagonists (anti‐TNF) are conflicting in patients